NOVARA PHARMACEUTICALS Trademark

Trademark Overview


On Friday, February 7, 2020, a trademark application was filed for NOVARA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the NOVARA PHARMACEUTICALS trademark a serial number of 88789113. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, September 8, 2020. This trademark is owned by Entrinsic Bioscience, Inc.. The NOVARA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds
novara pharmaceuticals

General Information


Serial Number88789113
Word MarkNOVARA PHARMACEUTICALS
Filing DateFriday, February 7, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, September 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2020

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the modified release of a wide variety of therapeutic agents for treating cystic fibrosis, iron irregularities, diarrhea, constipation, short bowel syndrome, asthma, psoriasis, ulcerative colitis, celiac disease, tumors, irritable bowel diseases, environmental enteropathy disorder, atopic dermatitis, allergic rhinitis, Crohn's disease, hemochromatosis, iron deficiency anemia, and wounds

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, September 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEntrinsic Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorwood, MA 02062

Party NameEntrinsic Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorwood, MA 02062

Trademark Events


Event DateEvent Description
Tuesday, September 8, 2020ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, September 8, 2020ABANDONMENT - AFTER PUBLICATION
Friday, September 4, 2020TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, September 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 20, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 12, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 6, 2020ASSIGNED TO LIE
Friday, March 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 27, 2020EXAMINER'S AMENDMENT ENTERED
Friday, March 27, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 27, 2020EXAMINERS AMENDMENT E-MAILED
Friday, March 27, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, March 26, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 11, 2020NEW APPLICATION ENTERED IN TRAM